Other authors have demonstrated that a transgenic mouse that expressed CCL2 under the GFAP promoter developed pertussis-induced reversible inflammatory encephalopathy and that CCL2 directed a Th1-biased inflammatory reaction, as shown by high levels of TNF-α, INFγ and IL-2 in the CNS. This evidence concerns the gene IL2 and pertussis.